• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AIZU OLYMPUS CO., LTD. EVIS LUCERA DUODENOVIDEOSCOPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AIZU OLYMPUS CO., LTD. EVIS LUCERA DUODENOVIDEOSCOPE Back to Search Results
Model Number JF-260V
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hemorrhage/Bleeding (1888); Perforation (2001); Pancreatitis (4481); Unspecified Hepatic or Biliary Problem (4493)
Event Date 06/03/2021
Event Type  Injury  
Event Description
Olympus reviewed the following literature "success and safety of needle knife papillotomy and fistulotomy based on papillary anatomy: a prospective controlled trial." literature summary this study aimed to evaluate the validity and safety of this individualized therapy, the initial success rate of biliary cannulation (isrbc), and complication rates of patients who underwent nkp and nkf were compared prospectively among different types of mdps and between two precut approaches.A total of 188 out of 1674 patients undergoing ercp satisfied the criteria for early precutting: 75 patients were assigned to the nkp group and 113 to the nkf group.The total initial success rate of biliary cannulation (isrbc) of the precut techniques (both nkp and nkf) for patients with dbc was 91.5%.The isrbc of patients in the nkp group was similar to that of the nkf group (90.7% vs 92.0%, p>.05).The isrbc of the patients in the swollen mdp subgroup (96.1%) was higher than that of patients in the distorted mdp subgroup (81.8%, p=.030).The total and specific complications of the patients of the nkp group were similar to those of the nkf group (p>.05).This study concluded that nkp and nkf, as selected based on mdp anatomy, are equally safe and highly efficient for patients with dbc to allow biliary cannulation.Selecting a precut method based on mdp anatomy is an efective and safe strategy for patients with dbc.Type of adverse events/number of patients acute pancreatitis (11).Bleeding (4).Cholangitis (1).Perforation (1).Initial unsuccess of biliary cannulation (16).This article includes 2 reports: (b)(6) : jf-260v was selected to represent jf 260 documented in the article.(b)(6) : kd-10q-1 was selected to represent kd-10-1 documented in the article.This report is 1 of 2 for - (b)(6) : jf-260v was selected to represent jf 260 documented in the article.
 
Manufacturer Narrative
The suspect device has not been returned to olympus for evaluation.The investigation is in process.The literature article is attached for additional information.Once the investigation has been completed, a supplemental report will be submitted with device evaluation results.
 
Manufacturer Narrative
This supplemental report is being submitted to provide additional information from the author and the legal manufacturer's investigation.The device history records (dhr) for this device could not be reviewed since the serial number was not provided.Olympus ships devices manufactured according to all applicable procedures and meet final product release criteria.A definitive root cause was not identified.Based on the available information, the legal manufacturer was unable to determine the probable cause of the adverse events since the device was not returned for evaluation.No malfunctions were reported.Olympus will continue to monitor field performance for this device.
 
Event Description
Additional information received from the author: the serial number is not available.No malfunctions occurred.The author reported the adverse events were attributed to the patient's underlying pathology and disease state and not the olympus device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVIS LUCERA DUODENOVIDEOSCOPE
Type of Device
DUODENOVIDEOSCOPE
Manufacturer (Section D)
AIZU OLYMPUS CO., LTD.
3-1-1 niiderakita
aizuwakamatsu-shi, fukushima 965-8 520
JA  965-8520
Manufacturer Contact
masaharu hirose
3-1-1 niiderakita
aizuwakamatsu-shi, fukushima 965-8-520
JA   965-8520
426422891
MDR Report Key15142131
MDR Text Key297037430
Report Number9610595-2022-00504
Device Sequence Number1
Product Code FDT
Combination Product (y/n)N
Reporter Country CodeCH
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 09/06/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberJF-260V
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 07/04/2022
Initial Date FDA Received08/01/2022
Supplement Dates Manufacturer Received08/09/2022
Supplement Dates FDA Received09/06/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Treatment
KD-10Q-1, LOT UNK; NON-OLYMPUS: GUIDEWIRE, SPHINCTEROTOME, GENERATOR
Patient Outcome(s) Other; Other; Required Intervention; Required Intervention;
-
-